ifa systems AG (HAM:IS8) ROE %: 2.52% (As of Dec. 2025) — 18% Above Median


HAM:IS8 ifa systems AG HAM:IS8
57 GF Score
Price €2.00
GF Value €2.51
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is ifa systems AG ROE %?

ifa systems AG HAM:IS8 57 ROE % is 2.52% as of Dec. 2025, which is 18% above its 10-year median of 2.13. GuruFocus rates HAM:IS8 with a GF Score™ of 57/100 and a GF Value™ of €2.51 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 628 Healthcare Providers & Services companies, ifa systems AG ranks worse than 60.67% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. ifa systems AG's annualized net income for the quarter that ended in Dec. 2025 was €0.18 Mil. ifa systems AG's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was €6.94 Mil. Therefore, ifa systems AG's annualized ROE % for the quarter that ended in Dec. 2025 was 2.52%.

The historical rank and industry rank for ifa systems AG's ROE % or its related term are showing as below:

HAM:IS8' s ROE % Range Over the Past 10 Years
Min: -77.19   Med: 2.13   Max: 14.67
Current: 2.52

During the past 13 years, ifa systems AG's highest ROE % was 14.67%. The lowest was -77.19%. And the median was 2.13%.

HAM:IS8's ROE % is ranked worse than
60.67% of 628 companies
in the Healthcare Providers & Services industry
Industry Median: 5.72 vs HAM:IS8: 2.52

ifa systems AG  (HAM:IS8) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=0.175/6.9375
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0.175 / 6.871)*(6.871 / 9.44)*(9.44 / 6.9375)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.55 %*0.7279*1.3607
=ROA %*Equity Multiplier
=1.86 %*1.3607
=2.52 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=0.175/6.9375
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (0.175 / 0.016) * (0.016 / 0.095) * (0.095 / 6.871) * (6.871 / 9.44) * (9.44 / 6.9375)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 10.9375 * 0.1684 * 1.38 % * 0.7279 * 1.3607
=2.52 %

Note: The net income data used here is one times the annual (Dec. 2025) net income data. The Revenue data used here is one times the annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


ifa systems AG ROE % Related Terms


ifa systems AG ROE % Historical Data

* Premium members only.

The historical data trend for ifa systems AG's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ifa systems AG ROE % Chart

ifa systems AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.67 1.74 -7.21 -0.47 2.52

ifa systems AG Semi-Annual Data
Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec23 Dec24 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.67 1.74 -7.21 -0.47 2.52

HAM:IS8 vs VEEV, BTSG, TEM: ROE % Comparison

For the Health Information Services subindustry, ifa systems AG's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ifa systems AG ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ifa systems AG's ROE % distribution charts can be found below:

* The bar in red indicates where ifa systems AG's ROE % falls into.


HAM:IS8
57GF Score
ifa systems AG HAM:IS8
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ifa systems AG ROE % Calculation

ifa systems AG's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=0.175/( (6.85+7.025)/ 2 )
=0.175/6.9375
=2.52 %

ifa systems AG's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Dec. 2024 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=0.175/( (6.85+7.025)/ 2 )
=0.175/6.9375
=2.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 2.52% mean?
ifa systems AG (HAM:IS8) has a ROE % of 2.52% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on ifa systems AG and its competitors. This is 18% above median its historical median of 2.13. According to the industry distribution chart, ifa systems AG ranks #381 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 60.7%.
Is ifa systems AG's ROE % too high?
ifa systems AG's current ROE % of 2.52% is 18% above median its 10-year median of 2.13. The Healthcare Providers & Services industry median ROE % is 5.72. ifa systems AG's value of 2.52% is 55.9% below this industry median. Based on the distribution chart, ifa systems AG ranks #381 out of 628 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, ifa systems AG has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ifa systems AG's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ifa systems AG ranks #381 out of 628 companies for ROE %. This places ifa systems AG in the lower half of its industry. The industry median ROE % is 5.72. ifa systems AG's value of 2.52% is 55.9% below this benchmark. While the company's 10-year median is 2.13 vs. the industry median of 5.72, ifa systems AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ifa systems AG's current ROE % of 2.52% is 55.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on ifa systems AG and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ifa systems AG's current ROE % is 2.52%, which is 18% above median its own 10-year median of 2.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ifa systems AG stock overvalued right now?
Based on GuruFocus' analysis, ifa systems AG (HAM:IS8) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.51, compared to a current price of €2.00 — trading 20.3% below its estimated fair value. The current ROE % is 2.52%, which is 18% above median its 10-year median of 2.13 and 55.9% below the Healthcare Providers & Services industry median of 5.72. ifa systems AG's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For ifa systems AG (HAM:IS8), the current ROE % is 2.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ifa systems AG (HAM:IS8) Overvalued in 2026?

Based on GuruFocus' analysis, ifa systems AG stock appears to be undervalued. The current stock price of €2.00 is trading 20.3% below its estimated GF Value™ of €2.51. GuruFocus considers ifa systems AG to be Modestly Undervalued.

Key valuation signals for HAM:IS8:

  • ROE %: 2.52% (18% above median its 10-year median of 2.13)
  • GF Value™: €2.51 vs. price of €2.00 (20.3% below fair value)
  • GF Score™: 57/100 with 4 warning signs
  • Industry Position: 55.9% below the Healthcare Providers & Services median (#381 of 628)

No single metric tells the full story. See the HAM:IS8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ifa systems AG Business Description

Address Augustinusstrasse 11b, Konigsdorf, Frechen, DEU, 50226
ifa systems AG develops, distributes and installs software solutions and components for ophthalmologists and eye clinics in the fast-growing health IT industry. Its products are divided into the Clinic, Practice, and Language Versions. Some of its product includes EMR (Electronic Medical Records); MDI (Medical Device Interface); Software Connection Platform; CDSS (Clinical Decision Support System); WFM Software (Workflow Management) and others.
57GF Score

Get the complete analysis for HAM:IS8

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.00
Price
€2.51
GF Value